Heartburn Drug Zantac Recalled
Drug-maker Sanofi is recalling its over-the-counter heartburn drug Zantac in Canada and the U.S. because of possible contamination.
In September, the U.S. Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac.
The agency said people could consider taking another heartburn medicine or contact their doctor.
Health Canada issued a precautionary request last month for companies to stop distributing the medication.
Several drugstore chains have already removed Zantac and generic versions from store shelves.